These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1135 related articles for article (PubMed ID: 27865383)

  • 1. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.
    Kostera J; Leckie G; Tang N; Lampinen J; Szostak M; Abravaya K; Wang H
    Tuberculosis (Edinb); 2016 Dec; 101():137-143. PubMed ID: 27865383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct detection of Mycobacterium tuberculosis and drug resistance in respiratory specimen using Abbott Realtime MTB detection and RIF/INH resistance assay.
    Tam KK; Leung KS; To SW; Siu GK; Lau TC; Shek VC; Tse CW; Wong SS; Ho PL; Yam WC
    Diagn Microbiol Infect Dis; 2017 Oct; 89(2):118-124. PubMed ID: 28780247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Abbott RealTime MTB and RealTime MTB INH/RIF Assays for Direct Detection of Mycobacterium tuberculosis Complex and Resistance Markers in Respiratory and Extrapulmonary Specimens.
    Hofmann-Thiel S; Molodtsov N; Antonenka U; Hoffmann H
    J Clin Microbiol; 2016 Dec; 54(12):3022-3027. PubMed ID: 27733630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective Diagnostic Accuracy Study of Abbott RealTi
    Howlett P; Nabeta P; Tukvadze N; Schumacher SG; Denkinger CM
    Microbiol Spectr; 2021 Sep; 9(1):e0013221. PubMed ID: 34406811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capacity of Abbott RealTi
    Hofmann-Thiel S; Molodtsov N; Duffner C; Kadyrov A; Kalmambetova G; Kabirov O; Rajabov A; Parpieva N; Sayfutdinov Z; Vogel M; Vogel H; Antonenka U; Hoffmann H
    Int J Tuberc Lung Dis; 2019 Apr; 23(4):458-464. PubMed ID: 31064625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abbott RealTime MTB and MTB RIF/INH assays for the diagnosis of tuberculosis and rifampicin/isoniazid resistance.
    Wang MG; Xue M; Wu SQ; Zhang MM; Wang Y; Liu Q; Sandford AJ; He JQ
    Infect Genet Evol; 2019 Jul; 71():54-59. PubMed ID: 30902741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the Abbott RealTime MTB and RIF/INH resistance assays for the detection of Mycobacterium Tuberculosis and resistance markers in sputum specimens.
    Araya BT; Ali KE; Geleta DA; Tekele SG; Tulu KD
    PLoS One; 2021; 16(5):e0251602. PubMed ID: 33979395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of cobas MTB and MTB-RIF/INH for Detection of Mycobacterium tuberculosis and Drug Resistance.
    de Vos M; David A; Duraisamy K; Nadarajan D; Noroc E; Penn-Nicholson A; Crudu V; Giri S; Maurer FP; Pati S; Stevens W; Scott L; Turuk J; Schumacher SG; Ruhwald M;
    J Mol Diagn; 2024 Aug; 26(8):708-718. PubMed ID: 38851386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy and usefulness of the Genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon? a cross-sectional study.
    Abanda NN; Djieugoué JY; Lim E; Pefura-Yone EW; Mbacham WF; Vernet G; Penlap VM; Eyangoh SI; Taylor DW; Leke RGF
    BMC Infect Dis; 2017 May; 17(1):379. PubMed ID: 28569148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the GenoType MTBDRplus assay for detection of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates in central Ethiopia.
    Bedewi Omer Z; Mekonnen Y; Worku A; Zewde A; Medhin G; Mohammed T; Pieper R; Ameni G
    Int J Mycobacteriol; 2016 Dec; 5(4):475-481. PubMed ID: 27931690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis Using the Quantamatrix Multiplexed Assay Platform System.
    Wang HY; Uh Y; Kim S; Cho E; Lee JS; Lee H
    Ann Lab Med; 2018 Nov; 38(6):569-577. PubMed ID: 30027701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug resistance in Mycobacterium tuberculosis clinical isolates from Brazil: phenotypic and genotypic methods.
    Miyata M; Pavan FR; Sato DN; Marino LB; Hirata MH; Cardoso RF; de Melo FA; Zanelli CF; Leite CQ
    Biomed Pharmacother; 2011 Sep; 65(6):456-9. PubMed ID: 21880463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a new automated Abbott RealTime MTB RIF/INH assay for qualitative detection of rifampicin/isoniazid resistance in pulmonary and extra-pulmonary clinical samples of
    Ruiz P; Causse M; Vaquero M; Gutierrez JB; Casal M
    Infect Drug Resist; 2017; 10():463-467. PubMed ID: 29263682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Analytical Evaluation of Four Centralized Platforms for the Detection of Mycobacterium tuberculosis Complex and Resistance to Rifampicin and Isoniazid.
    de Vos M; Scott L; David A; Trollip A; Hoffmann H; Georghiou S; Carmona S; Ruhwald M; Stevens W; Denkinger CM; Schumacher SG
    J Clin Microbiol; 2021 Feb; 59(3):. PubMed ID: 33268535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility, Ease-of-Use, and Operational Characteristics of World Health Organization-Recommended Moderate-Complexity Automated Nucleic Acid Amplification Tests for the Detection of Tuberculosis and Resistance to Rifampicin and Isoniazid.
    David A; de Vos M; Scott L; da Silva P; Trollip A; Ruhwald M; Schumacher S; Stevens W
    J Mol Diagn; 2023 Jan; 25(1):46-56. PubMed ID: 36243289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a Molecular Test for Detection of Mycobacterium tuberculosis Isolates Resistant to Rifampicin and Isoniazid.
    Benaissa E; Benlahlou Y; Bssaibis F; Maleb A; Elouennass M
    Clin Lab; 2022 Mar; 68(3):. PubMed ID: 35254025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the GenoType
    Stephen S; Muzhizhizhi D; Dhibi N; Chidemo T; Samaneka W; Matubu TA; Hakim JG; Chirenje ZM
    Int J Mycobacteriol; 2019; 8(1):83-88. PubMed ID: 30860184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the GenoType MTBDR assay for detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis complex isolates.
    Saglik I; Oz Y; Kiraz N
    Indian J Med Microbiol; 2014; 32(3):318-22. PubMed ID: 25008829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis].
    Gui XH; Xu P; Zhao M; Wang LL; Wu J; Li J; Gao Q; Mei J
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jan; 33(1):43-5. PubMed ID: 20368024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of genotype MTBDRplus line probe assay in detection of rifampicin and isoniazid resistance in comparison to solid culture drug susceptibility testing in a tertiary care centre of western Uttar Pradesh.
    Ahmed S; Shukla I; Fatima N; Varshney SK; Shameem M
    Indian J Med Microbiol; 2017; 35(4):568-574. PubMed ID: 29405151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.